Herediter anjiyoödem: Klasik antiödem tedaviler işe yaramaz

References (10)

1. Waytes AT, Rosen FS, Frank MM. Treatment of hereditary angiöedema with a vapor-heated C1 inhibitor concentrate. N Engl J Med. 1996; 334:1630-1634
2. Farkas H, Harmat G, Fust G, et al. Clinical management of hereditary angio-oedema in children. Pediatr Allergy Immunol. 2002; 13: 153-161
3. Pruet CW, Kornblut AD, Brickman C, et al. Management of the airway in patients with angioedema. Laryngoscope. 1983; 93: 749-755
4. Nujjens JH, Agostoni A, Aygoren-Pursun E, et al. Hereditary and acquired angioedema: problems and progress: proceedings of the third Cl esterase inhibitor deficiency workshop and beyond. J Allergy Clin Immunol 2004; 114:S51-131
5. Davis AE. The pathophysiology of hereditary angioedema. Clin Immunol. 2005; 114:3-9
6. Agostoni A, Cicardi M. Hereditary and acquired Cl-inhibitor deficiency: biological and clinical characteristics in 235 patients. Medicine (Bal timore) 1992; 71:206-215
7. Cugno M, Bergamasehini L, Uziel L, et al. Haemostasis contact system and fibrinolysis in hereditary angioedema. J Clin Chem Clin Biochem 1988; 26:423-427
8. Frank MM. Complement in the pathophysiology of human disease. N Engl J Med. 1987; 316: 1525-1530
9. Anderson MW, deShazo RD. Studies of the mechanism of angiotensinconverting enzyme (ACE) inhibitor-associated angioedema: the effect of an ACE inhibitor on cutaneous responses to bradykinin, codeine, and histamine. J Allergy Clin Immunol. 1990;85:856-858
10. Nielsen EW, Johansen HA, Hogasen K, et al. Activation of the complement, coagulation, fibrinolytic and kallikrein-kinin systems during attacks of hereditary angioedema. Immunopharmacology. 1996; 3